Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
JP Stock MarketDetailed Quotes
6489 Maezawa Industries
- 1231
- +2+0.16%
20min DelayMarket Closed Jan 9 15:30 JST
25.59BMarket Cap6.26P/E (Static)
1242High1223Low26.20KVolume1229Open1229Pre Close32.31MTurnover170052wk High0.25%Turnover Ratio20.79MShares97352wk Low196.65EPS TTM13.04BFloat Cap1700Historical High6.26P/E (Static)10.60MShs Float102Historical Low196.65EPS LYR1.55%Amplitude36.00Dividend TTM0.78P/B100Lot Size2.92%Div YieldTTM
Maezawa Industries Key Stats
Quarterly+Annual
YOY
| (FY)May 31, 2024 | (FY)May 31, 2023 | (FY)May 31, 2022 | (FY)May 31, 2021 | (FY)May 31, 2020 | (FY)May 31, 2019 | (FY)May 31, 2018 | (FY)May 31, 2017 | (FY)May 31, 2016 | (FY)May 31, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -47.56%1.78B | 3.69%3.4B | -23.85%3.28B | 245.46%4.3B | -3.86%1.25B | 174.95%1.3B | -54.23%471M | 516.60%1.03B | -109.66%-247M | 356.06%2.56B |
| Net profit before non-cash adjustment | 49.31%4.96B | 7.37%3.32B | -7.34%3.09B | 97.57%3.34B | 26.12%1.69B | 19.11%1.34B | 276.25%1.13B | -38.22%299M | -27.44%484M | 4.22%667M |
| Total adjustment of non-cash items | 10.75%546M | -2.95%493M | -3.42%508M | 0.19%526M | 3.75%525M | -6.64%506M | 17.83%542M | -57.05%460M | 102.84%1.07B | -19.02%528M |
| -Depreciation and amortization | 7.83%606M | 2.55%562M | 1.29%548M | 7.98%541M | 1.01%501M | 0.81%496M | 5.13%492M | -23.53%468M | -5.12%612M | 9.14%645M |
| -Reversal of impairment losses recognized in profit and loss | --9M | --0 | ---- | --18M | ---- | ---- | --16M | ---- | --323M | ---- |
| -Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -189.47%-34M | -56.82%38M |
| -Disposal profit | 9.09%24M | -15.38%22M | 30.00%26M | -23.08%20M | -27.78%26M | 63.64%36M | 147.83%22M | -284.00%-46M | -28.57%25M | 133.33%35M |
| -Net exchange gains and losses | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 51.00%-122M | ---249M |
| -Other non-cash items | -2.20%-93M | -37.88%-91M | -24.53%-66M | -2,550.00%-53M | 92.31%-2M | -316.67%-26M | -68.42%12M | -85.77%38M | 352.54%267M | 240.48%59M |
| Changes in working capital | -785.04%-3.73B | -28.35%-421M | -176.10%-328M | 144.34%431M | -76.41%-972M | 54.01%-551M | -545.35%-1.2B | 114.93%269M | -232.21%-1.8B | 159.49%1.36B |
| -Change in receivables | -264.46%-1.82B | -459.55%-498M | -368.42%-89M | 98.26%-19M | -772.80%-1.09B | 86.35%-125M | -317.58%-916M | 89.64%421M | 139.15%222M | -946.27%-567M |
| -Change in inventory | 141.18%628M | -351.24%-1.53B | 911.67%607M | 130.00%60M | -92.31%-200M | -180.00%-104M | 115.06%130M | -235.80%-863M | -1,051.85%-257M | 129.67%27M |
| -Change in payables | -314.35%-2.78B | 368.32%1.3B | -86.49%-483M | -362.50%-259M | -107.11%-56M | 198.01%788M | -405.66%-804M | 84.10%-159M | -229.87%-1B | 177.00%770M |
| -Change in accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.35%3M | 119.45%113M |
| -Provision for loans, leases and other losses | -1,289.29%-389M | -119.86%-28M | 179.66%141M | -385.48%-177M | 663.64%62M | -123.40%-11M | -64.39%47M | --132M | ---- | ---- |
| -Changes in other current assets | 242.05%301M | 123.47%88M | -163.88%-375M | 6.53%587M | 161.15%551M | -1,817.02%-901M | -106.06%-47M | 217.75%776M | -168.86%-659M | 659.65%957M |
| -Changes in other current liabilities | 32.93%327M | 290.70%246M | -153.97%-129M | 200.42%239M | -20.20%-238M | -150.51%-198M | 1,131.58%392M | 65.77%-38M | -276.19%-111M | 112.23%63M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -6.25%-17M | 15.79%-16M | 0.00%-19M | 13.64%-19M | 12.00%-22M | 21.88%-25M | 45.76%-32M | 21.33%-59M | 12.79%-75M | 7.53%-86M |
| Interest received (cash flow from operating activities) | 3.74%111M | 27.38%107M | 13.51%84M | 8.82%74M | 3.03%68M | 0.00%66M | -1.49%66M | 1.52%67M | 11.86%66M | 7.27%59M |
| Tax refund paid | -25.14%-1.11B | 13.38%-887M | -7.23%-1.02B | -132.93%-955M | -44.37%-410M | -11.37%-284M | -11.84%-255M | -25.27%-228M | -4.00%-182M | -14.38%-175M |
| Other operating cash inflow (outflow) | 0 | -1M | 0 | 97.37%-1M | -3,900.00%-38M | 200.00%1M | -1M | 0 | -20,600.00%-207M | -1M |
| Operating cash flow | -70.57%765M | 12.22%2.6B | -31.88%2.32B | 303.32%3.4B | -19.94%843M | 322.89%1.05B | -69.22%249M | 225.43%809M | -127.39%-645M | 297.90%2.36B |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -14.57%-700M | -48.30%-611M | 25.90%-412M | -19.31%-556M | 4.51%-466M | 19.07%-488M | -69.38%-603M | -10.22%-356M | -15.36%-323M | -23.35%-280M |
| Net intangibles purchase and sale | -109.09%-161M | -250.00%-77M | -120.00%-22M | -11.11%-10M | 60.87%-9M | -155.56%-23M | 55.00%-9M | ---20M | --0 | 41.18%-20M |
| Net investment product transactions | ---98M | --0 | --2M | --0 | ---- | --2M | ---- | --0 | 109.23%6M | ---65M |
| Repayment of advance payments to other parties and cash income from loans | 100.00%2M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | -50.00%1M | 0.00%2M | -60.00%2M | 25.00%5M | -20.00%4M |
| Net changes in other investments | 585.19%131M | -170.00%-27M | 54.55%-10M | -4.76%-22M | -2,000.00%-21M | 0.00%-1M | 66.67%-1M | -400.00%-3M | 150.00%1M | -200.00%-2M |
| Investing cash flow | -15.69%-826M | -61.90%-714M | 24.87%-441M | -18.59%-587M | 2.75%-495M | 16.69%-509M | -62.07%-611M | -21.22%-377M | 14.33%-311M | -42.91%-363M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 77.78%-28M | 75.10%-126M | -1,267.57%-506M | 68.10%-37M | -369.77%-116M | 106.11%43M | 70.13%-704M | -282.29%-2.36B | 476.97%1.29B | -121.09%-343M |
| Net common stock issuance | ---356M | --0 | -44.72%-288M | ---199M | --0 | --202M | --0 | --0 | --0 | --0 |
| Increase or decrease of lease financing | 52.63%-9M | 0.00%-19M | -18.75%-19M | -6.67%-16M | 6.25%-15M | -14.29%-16M | 62.16%-14M | 86.79%-37M | 37.64%-280M | 40.05%-449M |
| Cash dividends paid | -23.82%-551M | 0.89%-445M | -48.18%-449M | -23.17%-303M | -21.78%-246M | -38.36%-202M | 0.00%-146M | 11.52%-146M | -51.38%-165M | 14.17%-109M |
| Net other fund-raising expenses | 87.50%-2M | 0.00%-16M | -6.67%-16M | 16.67%-15M | -80.00%-18M | 28.57%-10M | 6.67%-14M | -275.00%-15M | 0.00%-4M | 91.67%-4M |
| Financing cash flow | -56.11%-946M | 52.58%-606M | -124.21%-1.28B | -44.30%-570M | -2,423.53%-395M | 101.94%17M | 65.64%-878M | -402.73%-2.56B | 193.26%844M | -228.92%-905M |
| Net cash flow | ||||||||||
| Beginning cash position | 12.55%11.47B | 6.22%10.19B | 30.51%9.59B | -0.65%7.35B | 7.78%7.4B | -15.32%6.86B | -20.76%8.11B | -1.10%10.23B | 11.73%10.34B | -7.42%9.26B |
| Current changes in cash | -178.73%-1.01B | 114.24%1.28B | -73.38%597M | 4,872.34%2.24B | -108.38%-47M | 145.24%561M | 41.59%-1.24B | -1,795.54%-2.12B | -110.30%-112M | 246.50%1.09B |
| Effect of exchange rate changes | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash adjustments other than cash changes | ---1M | ---- | ---- | 0.00%-1M | 96.30%-1M | -1,250.00%-27M | -100.00%-2M | 50.00%-1M | -100.00%-2M | ---1M |
| End cash Position | -8.79%10.46B | 12.55%11.47B | 6.22%10.19B | 30.51%9.59B | -0.65%7.35B | 7.78%7.4B | -15.32%6.86B | -20.76%8.11B | -1.10%10.23B | 11.73%10.34B |
| Free cash flow | -105.60%-107M | 2.85%1.91B | -34.09%1.86B | 666.03%2.82B | -30.96%368M | 246.03%533M | -184.30%-365M | 144.87%433M | -147.12%-965M | 225.95%2.05B |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |